385 related articles for article (PubMed ID: 30138942)
1. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
2. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
3. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
Huang Q; Huang J; Zeng Z; Luo J; Liu P; Chen S; Liu B; Pan X; Zang L; Zhou S
Life Sci; 2015 Mar; 124():41-9. PubMed ID: 25636810
[TBL] [Abstract][Full Text] [Related]
4. Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes.
Hou N; Luo MS; Liu SM; Zhang HN; Xiao Q; Sun P; Zhang GS; Luo JD; Chen MS
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1087-95. PubMed ID: 20738325
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes.
Irukayama-Tomobe Y; Miyauchi T; Kasuya Y; Sakai S; Goto K; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S358-61. PubMed ID: 15838320
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin.
Jen HL; Yin WH; Chen JW; Lin SJ
J Atheroscler Thromb; 2017 May; 24(5):508-517. PubMed ID: 27629528
[TBL] [Abstract][Full Text] [Related]
8. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
10. Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
Zhou X; Sun F; Luo S; Zhao W; Yang T; Zhang G; Gao M; Lu R; Shu Y; Mu W; Zhuang Y; Ding F; Xu C; Lu Y
Int J Biol Sci; 2017; 13(1):22-31. PubMed ID: 28123343
[No Abstract] [Full Text] [Related]
11. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
12. Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components.
Bell D; Zhao YY; Devine AB; McDermott BJ
Cell Physiol Biochem; 2008; 21(1-3):203-14. PubMed ID: 18209487
[TBL] [Abstract][Full Text] [Related]
13. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
Le K; Li R; Xu S; Wu X; Huang H; Bao Y; Cai Y; Lan T; Moss J; Li C; Zou J; Shen X; Liu P
Arch Biochem Biophys; 2012 Feb; 518(1):71-8. PubMed ID: 22198280
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta.
Smeets PJ; Teunissen BE; Planavila A; de Vogel-van den Bosch H; Willemsen PH; van der Vusse GJ; van Bilsen M
J Biol Chem; 2008 Oct; 283(43):29109-18. PubMed ID: 18701451
[TBL] [Abstract][Full Text] [Related]
15. Contractile activity is required for sarcomeric assembly in phenylephrine-induced cardiac myocyte hypertrophy.
Eble DM; Qi M; Waldschmidt S; Lucchesi PA; Byron KL; Samarel AM
Am J Physiol; 1998 May; 274(5):C1226-37. PubMed ID: 9612209
[TBL] [Abstract][Full Text] [Related]
16. The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARα-cyclophilin D interaction in cardiomyocytes.
Barreto-Torres G; Hernandez JS; Jang S; Rodríguez-Muñoz AR; Torres-Ramos CA; Basnakian AG; Javadov S
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(7):H749-58. PubMed ID: 25617357
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
Wang YS; Zhou J; Hong K; Cheng XS; Li YG
Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
Liang F; Wang F; Zhang S; Gardner DG
Endocrinology; 2003 Sep; 144(9):4187-94. PubMed ID: 12933694
[TBL] [Abstract][Full Text] [Related]
19. [MicroRNA-133a attenuates isoproterenol-induced neonatal rat cardiomyocyte hypertrophy by downregulating L-type calcium channel α1C subunit gene expression].
Wu Y; Wang YQ; Wang BX
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):507-13. PubMed ID: 24113045
[TBL] [Abstract][Full Text] [Related]
20. cAMP-mediated beta-adrenergic signaling negatively regulates Gq-coupled receptor-mediated fetal gene response in cardiomyocytes.
Patrizio M; Vago V; Musumeci M; Fecchi K; Sposi NM; Mattei E; Catalano L; Stati T; Marano G
J Mol Cell Cardiol; 2008 Dec; 45(6):761-9. PubMed ID: 18851973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
